RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 5, 2000, Pages 485-493

  Schmidt, A M ^a   Hofmann, M ^a   Taguchi, A ^a   Shi Du Yan, ^a   Stern, D M ^a  

^a Coll Physic/Surg Columbia Univ ^*  (United States)

Author keywords

Advanced glycation endproduct; Amphoterins; Amyloid; Calgranulins; S100 proteins

Indexed keywords

AMYLOIDOSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; GLYCATION; HUMAN; LIGAND BINDING; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0033635831     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13204     Document Type: Review

References (32)

1. Glucose and diabetic vascular disease
2. Role of oxidative stress in development of complications in diabetes
3. Structure elucidation of senescence crosslink from human extracellular matrix: Implication of pentoses in the aging process
4. Advanced glycosylation in diabetes and aging
5. Accumulation of Maillard products in skin collagen in diabetes and aging
6. Carboxymethyllysine is a dominant AGE antigen in tissue proteins
7. Pentosidine formation in skin correlates with severity of complications in individuals with longstanding IDDM
8. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface
9. Activation of RAGE: A mechanism for chronic dysfunction in diabetic vasculopathy and atherosclerosis
10. Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins
11. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression
12. A model for betaamyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
13. RAGE mediates a novel proinflammatory axis: The cell surface receptor for S100/calgranulin polypeptides
14. Activation of RAGE triggers a MAP kinase pathway regulated by oxidant stress
15. RAGE is a cellular binding site for amphoterin: Mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system
16. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
17. Characterization and functional analysis of the promoter of RAGE
18. Sp1 binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells
19. Tissue distribution of the receptor for advanced glycation endproducts (RAGE): Expression in smooth muscle, cardiac myocytes, and neural tissue in addition to vasculature
20. Expression of RAGE in peripheral occlusive vascular disease
21. The dark side of glucose
22. Lipoprotein and receptor interactions in vivo
23. The cellular and molecular mechanisms of diabetic complications
24. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes
25. AGEs on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications
26. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: Soluble RAGE blocks hyperpermeability
27. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE)
28. The adhesive and neurite-promoting molecule p30: Analysis of the amino terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons
29. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons
30. Neurotrophic protein S-100B stimulates glial cell proliferation
31. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils
32. Human brain S100 beta and S100 beta mRNA expression increases with age: Pathogenic implications for Alzheimer's disease